MiNK Therapeutics Inc. (NASDAQ: INKT)
$6.4150
-0.1850 ( -4.82% ) 42.7K
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.
Market Data
Open
$6.4150
Previous close
$6.6000
Volume
42.7K
Market cap
$26.16M
Day range
$6.2950 - $7.3200
52 week range
$4.5601 - $19.0000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Jun 05, 2024 |
| 4 | Insider transactions | 1 | Jun 05, 2024 |
| sc | Insider transactions | 1 | May 22, 2024 |
| 8-k | 8K-related | 11 | May 16, 2024 |
| 8-k | 8K-related | 15 | May 14, 2024 |
| 10-q | Quarterly Reports | 51 | May 14, 2024 |
| ars | Annual reports | 1 | Apr 30, 2024 |
| def | Proxies and info statements | 3 | Apr 29, 2024 |
| 8-k | 8K-related | 15 | Mar 21, 2024 |
| 10-k | Annual reports | 71 | Mar 21, 2024 |